Medical Device Market Validation to Secure $4m+ Venture Funding

We delivered a targeted validation campaign to help a pioneering medical devices startup secure over $4M in venture funding and FDA approval.


Context

Convincing Investors and Validating Fit

iSono Health, a San Francisco based Y-Combinator alum and venture-backed medical devices startup, was pioneering a 3D ultrasound body-scanning technology to revolutionise breast cancer screening. Despite their cutting-edge science, iSono faced a familiar startup hurdle: demonstrating real commercial traction, a critical requirement for both next-stage fundraising and regulatory preparation.

With an ambitious innovation but limited evidence of market adoption, iSono and one of its investors asked for expert help to build commercial proof points to deliver a successful funding round.

Approach

Commercial Proof in a Specialist Environment

Stepping into a pivotal partnership role, we collaborated with iSono and its stakeholders to design and execute an 8-week market validation campaign. Our approach was practical and outcomes-focused: we activated 11 customer acquisition channels to attract and engage potential early-stage testers and buyers for iSono’s novel technology.

Acting as embedded experts-in-residence, we partnered with the founders and core team while orchestrating a network of specialist domain experts to provide tailored support and market insight throughout the programme.

Customer Engagement:

We built a robust pilot pipeline by testing and validating 11 customer acquisition channels.

  • Industry Commitment: Secured clinical study partnerships with 8 leading US cancer research institutions, providing high-credibility third-party validation.

  • Clinician Adoption: Orchestrated an early adopter programme where 88% of OBGYN clinicians signed up for ongoing priority access, unlocking maximum levels of commercial validation achievable before FDA approval.

  • Venture Funding: Commercial proof paved the way for a fundraising round that exceeded $4 million.

Impact

Built Investor Confidence

Integrated Advisory: A seamless blend of strategic guidance and hands-on programme leadership elevated speed and relevance.

Domain Expertise: Rapid mobilisation of targeted experts allowed for nuanced, industry-specific validation and support.

Data-Led Execution: Every campaign decision was evidence-driven, with outcomes measured and iterated in real time.

By transforming strategic intent into credible commercial outcomes, we enabled iSono Health to fast-track their journey; winning investor confidence, industry traction, and the resources to take their innovation to the next stage.

 
Previous
Previous

Empowering Croydon’s Night-Time Economy

Next
Next

Advancing National Security Readiness through Digital Learning Innovation